ESC 365 - Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial - Update of patient characteristics and study timeline after interim analysis

ESC Premium Access

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial - Update of patient characteristics and study timeline after interim analysis

Session: Novel insight into thromboembolic stroke and transient ischemic attack

Topic: Prevention

Speaker: Doctor S. Poli (Tuebingen, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Sven Poli

Eberhard-Karls University of Tubingen, Tuebingen (Germany)

1 presentation

0 follower

4 more presentations in this session

Capacities of atrial fibrillation detection after stroke : a French nationwide survey

Speaker: Doctor C. Guidoux (Paris, FR)

Impact of excessive supraventricular ectopic activity detected in the acute phase of stroke or TIA on AF detection and death within 24 months - Results of the prospective MonDAFIS study

Speaker: Professor K. Haeusler (Wurzburg, DE)

Similarities and differences in risk factors for retinal artery occlusion and stroke.

Speaker: Ms M. Oerskov (Aalborg, DK)

Patient characteristics and clinical outcomes of type 2 myocardial infarction in patients with acute ischemic stroke in the united states

Speaker: Mr R. Ariss (Toledo, US)

Access the full session

Novel insight into thromboembolic stroke and transient ischemic attack

Speakers: Doctor S. Poli, Doctor C. Guidoux, Professor K. Haeusler, Ms M. Oerskov, Mr R. Ariss

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources